Poster Presentations


When you register in Vienna you will be advised of the location of your poster display board. Posters must be mounted on the display boards on Thursday 22nd May and may be removed on Sunday 25th May. Presenters are required to be present at their poster on Friday 23rd May from 13.00 - 14.00 and on Saturday 24th May from 10.30 - 11.00 to answer questions from delegates in relation to their material.

The dimensions of the display boards are 90 cm wide by 100 cm high. Materials for attaching your poster to the board will be available at the Registration Desk. Presenters are responsible for removing their poster from the display board. Any posters still on display at the end of the Congress will be removed by the Organisers, who will not be responsible for these materials.

 


Imaging And Functional Analysis

R. Carvalho, I. Ribeiro, N. Martins, C. Teixeira, A. Lima, G. Morgado, PORTUGAL
OCT in choroidal folds
C. Costa-Ferreira, M. Amorim, L. Duarte, M. Monteiro, J. Salgado-Borges, PORTUGAL
OCT decreased retinal thickness in monocular amblyopia
E.L. Czaplicka, I. Rospond-Kubiak, J. Kociêcki, POLAND
Age-related macular degeneration in 3D OCT images
A. Dmitriew, A. Frajdenberg, J. Kociecki, POLAND
Autofluorescence as the prognostic examination, compared to the fluorescein angiography in patients with AMD
J.J. Garcia-Medina, G. Scalerandi, S. Gonzalez-Ocampo, M. Garcia-Medina, M.D. Pinazo-Duran, V. Vila-Bou, SPAIN
One year follow-up of choroideremia with optical coherence tomography
M. Karolczak-Kulesza, M. Pietryga, A. Jankowiak, M. Brazert, J. Kociecki, J. Brazert, POLAND
Proportions of the eyeballs anterior to the posterior segment development in fetus in the prenatal period
I. Mili-Boussen, K. Errais, I. Amous, W. Zbiba, R. Zhioua, A. Ouertani, TUNISIA
Infracyanine green angiographic features in choroidal tumors
S. Natarajan, A. Maiti, M. Uparkar, A. Mukherjee, A. Dutta, J. Walinjkar, INDIA
Principal component analysis of multifocal electroretinogram in retinitis pigmentosa
S. Natarajan, S. Tosniwal, M. Uparkar, A. Athale, A. Maiti, A. Sivaraman, INDIA
Optic nerve head morphometry in central retinal vein occlusion
J. Pareja-Esteban, M.A.. Teus-Guezala, P. Drake-Casanova, I. Dapena-Sevilla, J. Paz-Moreno, SPAIN
Macular volume and foveal thickness evaluation in the presence of cataract by OCT 3
S. Patil, S. Pilli, D. Mathapati, M. Chandran, G. Ansari, G. Menon, UK
Comparison of retinal thickness versus manual measurement of height of pigment epithelial detachment on optical coherence tomography
M. Rougier, J.F. Korobelnik, J.F. Dartigues, C. Colin, P. Barberger-Gateau, C. Delcourt, FRANCE
Use of a simple reading test for the detection of case of late age-related maculopathy in large epidemiological studies
J. Siwiec-Proscinska, E.L. Czaplicka, J. Kociecki, POLAND
Usefulness of optical coherent tomography for monitoring patients treated with intravitreal injections of ranibizumab
M. Stur, O. Rafaeli, E. Ergun, AUSTRIA
Montitoring of high-risk AMD eyes with Preferential Hyperacuity Perimetry (PHP)
N. Taresh, B. Al-refaei, A. labib, YEMEN
Effect of steroid therapy on visual acuity and fundus picture in 3 cases of Vogt Koyanagi Harada Syndrome in Yemen
R.S. Thampy, D. Al-Nuaimi, N. Parry, W.S.T. Pollock, UK
Five-year follow-up of an intravitreal metallic foreign body without siderotic sequelae
J. Yoshimoto Neves, C. Lobo, J.G. Cunha-vaz, A. Sulzbacher, PORTUGAL
Macular thickness measured in diabetic macular edema morphological and functional analysis using RTA and SAP

New Concepts In Pathogenesis Of Choroidal & Retinal Diseases
A. Cimbalas, R. Asoklis, S. Galgauskas, LITHUANIA
Retinopathy in a patient with hepatitis c treated with Pegylated Interferon and Ribavirin: Case report
M. Delyfer, J.F. Korobelnik, M. Rougier, P. Barberger-Gateau, J.F. Dartigues, C. Delcourt, FRANCE
Age-related maculopathy, retinopathy and other retinal diseases in French elderly subjects : The Alienor study
J.J. Garcia-Medina, M. Garcia-Medina, V. Zanon-Moreno, S. Pons-Vazquez, R. Gallego-Pinazo, M.D. Pinazo-Duran, SPAIN
A five year follow-up of antioxidant supplementation in diabetic retinopathy
A. Javadzadeh, M. Rafeey, L. Ghojazadeh, IRAN
Idiopathic central serous chorioretinopathy and helicobacter pylori
A. Javadzadeh, A. Ghorbanihaghjo, N. Rashtchizadeh, N. Baharivand, IRAN
Serum level of lipoprotein (a), homocysteine and malondialdehyde in wet-type age-related macular degeneration
K. Kaljurand, I. Lind, M. Mällo, M. Parik, ESTONIA
ABCA4 gene mutations in Estonian patients with Stargardt disease
L. Konstantinidis, I. Mantel, J.A. Pournaras, L. Zografos, A.. Ambresin, SWITZERLAND
Intravitreal ranibizumab (Lucentis) for the treatment of myopic choroidal neovascularization
N. Kosanovic-Jakovic, A. Radosavljevic, E. Colak, L. Zoric, V. Jaksic, S. Milenkovic, YUGOSLAVIA
Parameters of serum antioxidative defence in patients with exudative age-related macular degeneration (AMD)
N. Kosanovic-Jakovic, A. Radosavljevic, V. Dimitrijevic-Sreckovic, E. Colak, L. Zoric, A. Ilic, YUGOSLAVIA
Obesity and plasma lipoproteins as risk factors for exudative age-related macular degeneration (AMD)
V. Krylov, S. Sakhnov, RUSSIA
Retinal detachment probability in myopes after laser cataract extraction (LCE): 2 year follow-up
K. Ma, J. Xu, X. Yang, C. Han, N. Zhang, N. LIU, CHINA
A Chinese family with autosomal dominant central areolar choroidal dystrophy: Clinical features and linkage study
H. Mensink, J. Martinez-Ciriano, T. Missotten, NETHERLANDS
Various treatment options for myopic choroidal neovascularization and visual outcome
I. Mili-Boussen, K. Errais, A. Chebil, I. Amous, A. Ouertani, TUNISIA
Bilateral cat scratch disease neuroretinitis
Y. Nochez, Marie Laure Le Lez, Emmanuelle Lala, Pierre Jean Pisella, FRANCE
Ranibizumab in treatment of peripapillary choroidal neovascularization
V. Polanska, O. Sery, Z. Fojtik, Z. Hlinomazova, CZECH REPUBLIC
Ocular complications in the posterior pole due to vasculitis in patients with rheumatoid arthritis and association with -308 polymorphism tumour necrosis factor alpha gene
A. Soleymani, S.A. Rasulinejad, E. Mehdipour, E. Khalilian, IRAN
Evaluation of the effect of fasting on intraocular pressure (IOP) in normal individuals and damage of nerve fiber layer
Y. Yamaguchi, T. Otani, S. Kishi, JAPAN
The origin of the intermediate line between IS/OS and RPE in cross-sectional image of spectral domain OCT
H.S. Yoon, S.Y. Han, J.H. Kang, KOREA, SOUTH
Intravitreal Bevacizumab (Avastin) for myopic choroidal neovascularization

New Therapies For ARMD
K. Aleksandra, Sevšek Davorin, Jaki-Mekjavic Polona, Urbancic Mojca, SLOVENIA
Combined therapy for neovascular form of age-related macular degeneration with photodynamic therapy and intravitreal injections of ranibizumab. A 12 - month progress report
F. Ali, N. Armogan, CANADA
Heparin-induced extracorporeal lipoprotein precipitation therapy for dry AMD: Blood parameter and retinal morphology changes related to mechanisms of action
G. Banerjee, N. Horgan, J. Park, C. Egan, A. Tufail, P. Hykin, UK
Management of choroidal neovascularization secondary to angioid streaks with anti-VEGF therapy
H. Z. Buyukyildiz, G. Muftuoglu, TURKEY
Bevacizumab for idiopathic juxtafoveal choroidal neovascularization in a young woman
Â. Carneiro, Manuel Falcão, Elisete Brandão, Fernando Falcão-Reis, PORTUGAL
Intravitreal Bevacizumab for treatment of choroidal neovascularization in age-related macular degeneration- Short-term results
T. Diago, J. Pulido, SPAIN
Combination therapy of Intravitreal Ranibizumab with oral Sorafenib in neovascular age-related macular degeneration
C. Franzetti, C. Pisano, V. Ferrara, V. Belloli, ITALY
Intravitreal Bevacizumab as primary treatment for subfoveal and juxtafoveal choroidal neovascularization in pathologic myopia associated to lacquer cracks: Efficacy and safety
T. Galbinur, E. Banin, E. Averbukh, I. Hemo, I. Chowers, ISRAEL
Initial visual acuity and choroidal neovascularization lesion characteristics in the clinic setting and its impact on outcome in patients with neovascular age-related macular degeneration
E. Hughes, R. Das-Bhaumik, D. Lindfield, S. Horgan, UK
Trends in photodynamic therapy (PDT) for wet age-related macular degeneration (AMD) use in South-West London
L. Konstantinidis, R. De Haller, I. Mantel, J.A. Pournaras, L. Zografos, A. Ambresin, SWITZERLAND
Retinal pigment epithelial tears after intravitreal ranibizumab injection for vascularized pigment epithelium detachment secondary to age-related macular degeneration
D Lui, V Lee, C.L Li, A.H. Fan, D Lam, CHINA
Intravitreal Ranibizumab treatment for macular diseases in Hong Kong: A tertiary eye centre experience
K. Mousavi, J. Casado, S. Moreno, SPAIN
Macugen for the treatment of neovascular age related macular degeneration (AMD)
J. Park, E. Sohn, A. Tufail, C. Egan, UK
Evaluation of retreatment guidelines for type II choroidal neovascular membranes
R. Peddada, USA
Successful treatment of wet age-related macular degeneration (AMD) with Avastin®: A retrospective observational study
N. Pozdeyeva, A. Voskresenskaya, RUSSIA
Management of submacular hemorrage with intravitreal injection of tissue plasminogen activator (Gemase), bevacizumab (Avastin) and pneumatic displacement
E. Rencova, J. Studnicka, M. Blaha, M. Blazek, V. Blaha, D. Solichova, CZECH REPUBLIC
Stopping the progression of dry form of age-related macular degeneration (AMD) to wet form by using Hemorheopheresis
D. Risimic, V. Jaksic, S. Milenkovic, M. Stojkovic, N. Jakovic, L. Ivankovic, YUGOSLAVIA
Efficacy of intravitreal Bevacizumab on different types of subfoveal lesions in exudative age-related macular degeneration
J.L. Robledo, I.F. Soria, E. Carrazana, F. Garcia-Contreras, MEXICO
Public health impact of neovascular age-related macular degeneration treatments in Mexico
A. Samad, A. MacDonald, CANADA
Severe recurrent uveitis following sensitization to intravitreal Bevacizumab
Z.S. Soheili, H. Akrami, K. Khalooghi, H. Ahmadieh, M. Rezaei Kanavi, S. Samiei, IRAN
Retinal pigment epithelial cell culture on amniotic membrane
J.H. Song, S.J. Lee, J.H. Bae, O.W. Kwon, KOREA, SOUTH
Short-term efficacy of intravitreal Ranibizumab for polypoidal choroidal vasculopathy
B. Stoffelns, C. Kramann, K. Schoepfer, GERMANY
Transpupillary Thermotherapy (TTT) for choroidal neovascular membranes (CNVs) in age-related macular degeneration (AMD)
P. Van Etten, J.P. Martinez-Ciriano, L.I. van den Born, G.S. Baarsma, T. Missotten, NETHERLANDS
Intravitreal Bevacizumab injections: 1 year safety in a cohort of 673 patients
F. Vaz, T. Ferreira, R. Avelino, H. Urbano, S. Donato, A. Rodrigues, PORTUGAL
Intravitreal injection of Bevacizumab for neovascularization in age-related macular degeneration and proliferative diabetic retinopathy - preliminary results
C. Veronese, G. Staurenghi, ITALY
A unique device to treat the feeder vessels alone or in combination with anti-VEGF in age-related macular degeneration

Paediatric Retina
R. Biswas, S. Sinha, D. Ratra, S. Sarkar, INDIA
Pattern of Retinopathy of Prematurity (ROP) in eastern India
E. Compains Silva, H. Heras-Mulero, V. Garrido Contreras, M.A. Ardanaz Aldave, M.B. Goldaracena Tanco, SPAIN
Bilateral macular coloboma. A frequent manifestation in familial hypomagnesemia, hypercalciuria with nephrocalcinosis and other renal diseases
M. Czeglédi, HUNGARY
Unusual case report: Microphtalmos with retinal fold
T. Ferreira, H. Urbano, R. Avelino, A.P. Mendonça, A. Cardoso, PORTUGAL
Bietti’s Crystalline Dystrophy: A case report
A. Gotz-Wieckowska, E. Strauss, J. Gadzinowski, A. Pawlak, POLAND
Associations between advancement of retinopathy of prematurity and ACE I/D genotypes in relation to the major morbidities co-occurrence
B.J. Langner-Wegscheider, Y. El-Shabrawi, J. Wagner, E. Ring, C. Mache, A. Wedrich, AUSTRIA
Posterior segment involvement in tubulointerstitial nephritis and uveitis (TINU) syndrome
J.M. Marín Sánchez, E. Rubio Velázquez, M. Hernández Martínez, SPAIN
Tent-shaped retinal detachment in retinopathy of prematurity. Surgical treatment
M. Rafeey, A. Javadzadeh, IRAN
Chorioretinitis in neonatal cholestasis

Retinal Detachment
J. Díaz-Cascajosa, I. Vela, J.A. Buil, F. Bassaganyas, N. Rosello, S. Bojados, SPAIN
Prophylactic vitrectomy and silicon oil for prevention of retinal detachment associated to cytomegalovirus retinitis
S. Jiménez-Prada De Miguel, J.M. López López, J.R. Juberías Sanchez, M.R. Sanabria Ruiz -Colmenares, SPAIN
Long-term persistence of subretinal fluid after retinal detachment surgery
A. Liaska, GREECE
Retinal detachment after phacoemulcification and posterior chamber intraocular lens implantation
S. Mittal, J. Thind, INDIA
Scleral buckling without sutures - possibility and limitations
N. Pozeyeva, A. Voskresenskaya, RUSSIA
The surgical technique for silicon oil removal from the vitreous cavity with 23-gauge sutureless system

Surgical Retina And Macular Surgery
S. Alpatov, A. Shchuko, V. Malyshev, RUSSIA
Surgical repositioning of chronic macular hole margins
Y. Bayborodov, RUSSIA
A comparative analysis of results of macular hole surgical treatment with and without staining agent
M. Cakir, O. Cekic, H. Erdogan, A.T. Yazýcý, S. Bayraktar, O.F. Yilmaz, TURKEY
Management of retinal detachments with inferior breaks
M. Cakir, O. Cekic, S. Yazgan, S. Bayraktar, O.F. Yilmaz, TURKEY
Acute endophthalmitis following 23-gauge sutureless transconjunctival vitrectomy
O. Cekic, M. Cakir, G. Pekel, E. Bozkurt, S. Bayraktar, O.F. Yilmaz, TURKEY
Anatomic and functional success rates in complicated retinal detachment treated with pars plana vitrectomy and large relaxing retinotomy
E. Eting, E. Pras, I. Avni, ISRAEL
Anterior hyaloidal neovascularisation after cataract surgery in an ischemic diabetic eye
M. Forlini, P. Rossini, C. Forlini, ITALY
23-25 gauge mini-invasive surgery: No limits
M. Forlini, P. Rossini, C. Forlini, ITALY
Double tamponade (PDMS-F6H8) in the treatment of retinal detachment with central hole in high myopia
V. Hegde, D. Mitry, H. Bennett, J. Singh, UK
Ultrasound in vitreous haemorrhage study
G. Ky Lee, C.W. Tsang, B. To Cheung, C. Yf Yuen, T. Yy Lai, R. F Lam, HONG KONG
Safety and efficacy of Transconjunctival 23-gauge Sutureless Vitrectomy: A series of 101 consecutive cases
J.M. López López, S. Jiménez-Prada de Miguel, M.R. Sanabria Ruiz-Colmenares, J.R. Juberías Sanchez, SPAIN
Four-month-delayed removal of subfoveal perfluorocarbon liquid
V. Sosnovskiy, Svetlana Sdobnikova, Vladimir Surguch, Natalia Troitskaya, Alexander Sidamonidze, RUSSIA
Possible ways of intraoperative application of recombinant prourokinase during complicated vitrectomy
V. Sosnovskiy, S. Sdobnikova, V. Surguch, N. Troitskaya, A. Sidamonidze, RUSSIA
Recombinant prourokinase and gas injection in patients with dense submacular hemorrhage due to AMD and ocular trauma
J.I. Vela, J. Díaz-Cascajosa, J. Crespí, N. Roselló, S. Bojados, J.A. Buil, SPAIN
Pupillary block glaucoma in phakic eyes using 5000 Centistoke silicone oil

Tumours And Hereditary Diseases
Y. Belyy, A. Tereshchenko, P. Volodin, A. Shatskih, M. Kaplan, B. Ruteniy, RUSSIA
Experimental substantiation for transpupillary photodynamic therapy with chlorine photosensitizer using for choroidal melanoma treatment
A. Chinchurreta, SPAIN
Maculopathy in curschmann-steinert myotonic dystrophy
C. Costa-Ferreira, J. Ferreira, R. Soares, J. Chibante Pedro, J. Salgado-Borges, PORTUGAL
Usher Syndrome
C.R.. Kim, Y.D. Kim, S.T. Lim, KOREA, SOUTH
Choroidal osteoma masquerading as central serous chorioretinopathy
S. Mittal, J. Thind, INDIA
Photodynamic therapy using modified protocol for the management of juxta-papillary capillary hemangioma
G. Morgado, I. Ribeiro, C. Teixeira, A. Lima, N. Martins, PORTUGAL
Fundus albipunctatus associated with cone dystrophy
E. Pras, E. Eting, A. Abu, I. Avni, ISRAEL
A frameshift mutation in theprominin lkegene [PROML1] is associated with autosomalrecessive cone-rod dystrophy [CORD] and high myopia
S. Saakyan, A. Amiryan, R. Tatskov, G. Kruzhkova, RUSSIA
The use of high frequency duplex scanning in complex diagnostics of retinoblastoma
E. Wylegala, A. Lyssek-Boron, W. Mankowski, S. Teper, POLAND
Optical Coherence Tomography and Electro-oculography in diagnosing adult-onset vitelliform macular dystrophy

Vascular Diseases And Diabetic Macular Edema
M.M. Amorim, M. Monteiro, R. Soares, C. Ferreira, B. Macedo, J. Salgado Borges, PORTUGAL
Central retinal vein occlusion in a 18 year-old girl: A case report
G. Ansari, R. Rajendram, M. Chandran, S. Patil, D. Mathapati, G. Menon, UK
Comparison of single intravitreal triamcinolone treatment in diabetic and non diabetic macular oedema
G. Ansari, R. Rajendram, M. Chandran, S. Patil, D. Mathapati, G. Menon, UK
Efficacy of single intravitreal triamcinolone injection for the treatment of chronic macula oedema in vein occlusions
L. Antico, R. Nicoletti, E. Tito, V. Gioia, M. Moscato, D. Santangelo, ITALY
Systemic complications associated with bevacizumab therapy in oncology and ophthalmology use
B. Bodaghi, G. Kobelt, A. Brézin, E. Heron, M. Labetoulle, J. Sahel, FRANCE
One year analysis of the cost of uveitis treatment: A retrospective chart review in France
R. Carvalho, P. Rodrigues, N. Martins, C. Teixeira, A. Lima, PORTUGAL
Different therapeutic strategies for treating choroidal neovascularization associated with optic disk drusen
O. Cekic, M. Cakir, N. Alagoz, S. Bayraktar, O.F. Yilmaz, TURKEY
Management of epimacular membrane and refractory macular edema secondary to idiopathic parafoveal telangiectasis
K.S. Choi, J.. Heo, S.Y. Park, KOREA, SOUTH
Laser photocoagulation combined with intravitreal bevacizumab injection in proliferative diabetic retinopathy
Z. Dubská, K. Sedláková, CZECH REPUBLIC
Parafoveal teleangiectasias - clinical picture and treatmet in our group of patients
J. Dusová, E. Rencová, J. Studnièka, D. Hejcmanová, V. Korda, CZECH REPUBLIC
Intravitreal injection of triamcinolon acetonide for the treatment of macular edema. One-year results
K. Elmas, A. Altýnsoy, E. Ozkilic, Ö. Bilen, A. Ertan, TURKEY
Intravitreal Bevacizumab treatment for traumatic choroidal neovascular membranes
K. Elmas, Ali Altýnsoy, Ersel Ozkilic, Özgür Bilen, Aylin Ertan, TURKEY
Effect of cataract surgery combined with itravitreal Bevacizumab and Triamcinolone Injection on progression of diabetic retinopathy
F.C. Erdurman, A.H. Durukan, T. Mumcuoglu, V. Hurmeric, S. Karagul, TURKEY
Intravitreal Bevacizumab treatment of macular edema secondary to retinal venous occlusive disease
E. Eting, E. Pras, L. Muzmacher, S. Schwartz, I. Avni, ISRAEL
Myopic CNV treated with Bevacizumab
R. Halfeld Furtado De Mendonça, L. Colella, S. Donati, L. Pannarale, ITALY
Bevacizumab in retinal vascular disease
R. Halfeld Furtado De Mendonça, O. de Oliveira Maia Júnior, D. Araújo Ferraz, W. Yukihiko Takahashi, ITALY
Combined treatment for primary vascoproliferative retinal tumour
H. Heras-Mulero, E. Compains Silva, J.I. Molinuevo Ruiz de Zárate, SPAIN
Photodynamic therapy for a pigment epithelial hyperplasia due to idiopathic juxtafoveal retinal telangiectasis (type 1b)
M.C. Hernaez-Ortega, J. León-Carrión, E. Soto-Pedre, SPAIN
Intravitreal Bevacizumab for the treatment of recurrent post-vitrectomy diabetic vitreous hemorrhages
M.C. Hernaez-Ortega, E. Soto-Pedre, SPAIN
Optimal screening intervals for early detection of sight-threatening diabetic retinopathy. A six-year retrospective follow-up study
V. Jaksic, S. Milenkovic, N. Jakovic, M. Mavija, D. Vuksa, D. Stamenkovic, YUGOSLAVIA
Retinal vascular disorders in patients on hemodilaysis
J. Jonas, Liang Xu, Xi Xie, Yaxing Wang, GERMANY
Ocular and systemic factors associated with diabetes mellitus in the adult population in rural and urban China. The Beijing eye study
J. Jost, L. Xu, X. Xie, Y. Wang, GERMANY
Diabetic retinopathy and mortality. The Beijing eye study
B. Kaderli, R. Avci, O. Gelisken, O. Yalcinbayir, A. Yucel, U. Inan, TURKEY
Intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide in cases of bilateral diffuse diabetic macular oedema
P. Maharajan, J. Khan, M. Issa, S. Dhar-Munshi, UK
Acute retinal necrosis - fear, frustration and fascination
S.S. Mangat, B. Kapoor, M. Poole, S. Sivaprasad, UK
The prevalence of visual impairment in patients with screen-positive diabetic retinopathy
M. Mavija, V. Jaksic, S. Milenkovic, N. Jakovic, D. Risimic, BOSNIA HERZEGOVINA
Hypertensive retinopathy in pre-dialysed and dialysed patients
E. Mavrikakis, N. Kanchanaranya, L. Quirino, P. Kertes, R. Devenyi, W.C. Lam, CANADA
A pilot study of Bevacizumab (Avastin) for anterior segment neovascularization with neovascular glaucoma
C. Novais, M.J. Furtado, B. Pessoa, J. Melo-Beirão, A. Meireles, PORTUGAL
Intravitreal Pegaptanib (Macugen) on diabetic macular edema, our first results
T. Otani, Y. Yamaguchi, S. Kishi, JAPAN
Photoreceptor damages and visual acuity in diabetic macular edema
A. Pinna, A. Zinellu, S. Dore, L. Dessole, C. Carru, ITALY
Plasma thiols and taurine levels in central retinal vein occlusion
J.L. Rosales Meneses, L.J. Flores Ovalles, A. Jacome, VENEZUELA
Intravitreal Avastin for perifoveal detachment in Idiopathic perifoveal telangiectasia
J.L. Rosales Meneses, L.J. Flores Ovalles, A. Jacome, VENEZUELA
Avastin for diabetic macular edema in previously vitrectomized eyes
C. Sanghvi, R. McLauchlan, C. Delgado, L. Young, S. Charles, P. Stanga, UK
Initial experience with the Pascal®: Photocoagulator - a pilot study of 75 procedures
M. Shahsuvaryan, ARMENIA
Venous occlusion of the retina: Medical therapy
I. Steinbrugger, R. Maier, A. Haas, A. Wedrich, O. Schmut, M. Weger, AUSTRIA
Role of the tumor necrosis factor alpha -308G: A gene polymorphism in central retinal vein occlusion
B. Stoffelns, C. Kramann, K. Schoepfer, GERMANY